BillsBills 119th Congress S. 2292 S. 2292 · Senate bill · 119th Congress
Over-the-Counter Monograph Drug User Fee Amendments Introduced Jul 15, 2025 Reported by committee Sep 8, 2025 Passed the Senate (not yet) Passed the House (not yet) Law (not yet) Latest action, Sep 8, 2025 : Placed on Senate Legislative Calendar under General Orders. Calendar No. 152.
What it would change (5) About this text
5 sections of the Code · 54 changes asked for
Text: reported in Senate Reported The text a committee sent back to its chamber, often with changes, recommending a vote. , Sep 8, 2025
The other version Official text on Congress.gov
Written by AIWhat this bill would change in the Code
The bill would add two requirements to the rules for new and nonprescription drugs. For companies wanting to switch a prescription drug to nonprescription sale, it would let them ask the FDA for a meeting to plan studies and the application, with the Secretary required to issue guidance within 18 months and publish a plan to engage stakeholders within 1 year. For topical nonprescription drugs sold without an approved application, the Secretary would have to use standards allowing real world evidence to supplement clinical trial evidence, and consider non-animal testing methods, issuing new draft guidance on them within 1 year of enactment. Existing safety and effectiveness standards would not change.
Summed up from the notes on 2 of the 5 sections the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
21 U.S.C. Chapter 9 · Federal Food, Drug, and Cosmetic Act 5 sections § 355 New drugs Shown § 355h Regulation of certain nonprescription drugs that are marketed without an approved drug application Shown § 379j–71 Definitions 1 of 4 shown § 379j–72 Authority to assess and use OTC monograph fees 8 of 26 shown § 379j–73 Reauthorization; reporting requirements 1 of 6 shown